Search Results - "do Carmo, Helison R"

Dapagliflozin effect on endothelial dysfunction in diabetic patients with atherosclerotic disease: a randomized active-controlled trial by Sposito, Andrei C, Breder, Ikaro, Soares, Alexandre A S, Kimura-Medorima, Sheila T, Munhoz, Daniel B, Cintra, Riobaldo M R, Bonilha, Isabella, Oliveira, Daniela C, Breder, Jessica Cunha, Cavalcante, Pamela, Moreira, Camila, Moura, Filipe A, de Lima-Junior, Jose Carlos, do Carmo, Helison R P, Barreto, Joaquim, Nadruz, Wilson, Carvalho, Luiz Sergio F, Quinaglia, Thiago

“…The glucose-lowering independent effect of sodium glucose cotransporter-2 inhibitors (SGLT2i) on arterial wall function has not yet been clarified. This study…”
Get full text

Rationale and design of the expanded combination of evolocumab plus empagliflozin in diabetes: EXCEED-BHS3 trial by Breder, Ikaro, Cunha Breder, Jessica, Bonilha, Isabella, Munhoz, Daniel B., Medorima, Sheila T. Kimura, Oliveira, Daniela C., Carmo, Helison R. do, Moreira, Camila, Kontush, Anatol, Zimetti, Francesca, Zanotti, Ilaria, Carvalho, Luiz Sergio F., Nadruz, Wilson, Muscelli, Elza, Quinaglia, Thiago, Sposito, Andrei C.

“…Background: Patients with type 2 diabetes mellitus (T2DM) remain at increased cardiovascular residual risk and endothelial dysfunction, even after optimizing…”
Get full text

Effect of Remote Ischaemic Conditioning on the Inflammatory Cytokine Cascade of COVID-19 (RIC in COVID-19): a Randomized Controlled Trial by Lukhna, Kishal, do Carmo, Helison R. P., Castillo, Alejandro Rossell, Davidson, Sean M., Geffen, Hayli, Giesz, Sara, Golforoush, Pelin, Bovi, Ticiane Gonçalez, Gorag, Diana, Salama, Alan, Imamdin, Aqeela, Kalkhoran, Siavash, Lecour, Sandrine, Perroud Jr, Mauricio W., Ntsekhe, Mpiko, Sposito, Andrei C., Yellon, Derek M.

“…Purpose Patients hospitalized with COVID-19 may develop a hyperinflammatory, dysregulated cytokine “storm” that rapidly progresses to acute respiratory…”
Get full text

Evolocumab on top of empagliflozin improves endothelial function of individuals with diabetes: randomized active-controlled trial by Sposito, Andrei C, Breder, Ikaro, Barreto, Joaquim, Breder, Jessica, Bonilha, Isabella, Lima, Marcus, Oliveira, Alessandra, Wolf, Vaneza, Luchiari, Beatriz, do Carmo, Helison R, Munhoz, Daniel, Oliveira, Daniela, Coelho-Filho, Otavio R, Coelho, Otavio R, Matos-Souza, Jose Roberto, Moura, Filipe A, de Carvalho, Luiz Sergio F, Nadruz, Wilson, Quinaglia, Thiago, Kimura-Medorima, Sheila T

“…Sodium-glucose cotransporter 2 inhibitors (SGLT2i) improve endothelial dysfunction and reduce cardiovascular events in individuals with type 2 diabetes (T2D)…”
Get full text

RIC in COVID-19—a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19 by Davidson, Sean M., Lukhna, Kishal, Gorog, Diana A., Salama, Alan D., Castillo, Alejandro Rosell, Giesz, Sara, Golforoush, Pelin, Kalkhoran, Siavash Beikoghli, Lecour, Sandrine, Imamdin, Aqeela, do Carmo, Helison R. P., Bovi, Ticiane Gonçalez, Perroud, Mauricio W., Ntsekhe, Mpiko, Sposito, Andrei C., Yellon, Derek M.

“…Purpose Coronavirus disease 19 (COVID-19) has, to date, been diagnosed in over 130 million persons worldwide and is caused by severe acute respiratory syndrome…”
Get full text

Correction to: RIC in COVID-19—a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19 by Davidson, Sean M., Lukhna, Kishal, Gorog, Diana A., Salama, Alan D., Castillo, Alejandro Rosell, Giesz, Sara, Golforoush, Pelin, Kalkhoran, Siavash Beikoghli, Lecour, Sandrine, Imamdin, Aqeela, do Carmo, Helison R. P., Bovi, Ticiane Gonçalez, Perroud, Mauricio W., Ntsekhe, Mpiko, Sposito, Andrei C., Yellon, Derek M.

“…A Correction to this paper has been published: https://doi.org/10.1007/s10557-021-07223-w…”
Get full text